Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1986-02-13
1988-06-07
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31185
Patent
active
047497190
ABSTRACT:
Pantetheine-S-sulfonic acid and/or its salt(s) have(has) an effect of curing and preventing pigmentation in the skin, an effect of improving rough skin and a curative effect to wounds, burns and the like, therefore being used for agents for epidermis.
REFERENCES:
patent: 3803119 (1974-04-01), Tamura et al.
patent: 3876799 (1975-04-01), Tamura et al.
Hayakawa et al., Acta Vitaminol Enzymol., I, 109 (1985).
Nakamura, H. et al, "Growth Responses of Bifidobacterium bifidum to S-Sulfonic Acid-Type Pantetheine Related Compounds" Japan. J. Microbiol. vol. 16 (2) 239-242 (1972).
Kopelevich, V. M. et al, "Research of Acyl Group Carriers. XIII New Method of Synthesis of D-(+)-S-Sulfopantetheine and its Conversion to Coenzyme Forms of Vitamin B.sub.3 in Animals" Khim.Farm.Zh., vol. 12 (8), pp. 72-75 (1978).
Moiseenok, A. G. et al "Antiinflammatory and Coenzyme Activity of Pantothenic Acid Derivatives in Adjuvant Arthritis", Khim. Farm. Zh., vol. 15(6), pp. 76-81 (1981).
Maruya Yoshiji
Taki Toshio
Chan Nicky
Sogo Pharmaceutical Company Limited
LandOfFree
Method of treating skin pigmentation abnormalities with pantethe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating skin pigmentation abnormalities with pantethe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating skin pigmentation abnormalities with pantethe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-845093